News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,257 Results
Type
Article (15075)
Company Profile (299)
Press Release (267877)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80060)
Career Advice (163)
Deals (13395)
Drug Delivery (39)
Drug Development (51214)
Employer Resources (31)
FDA (5863)
Job Trends (5227)
News (145848)
Policy (10138)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (946)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21822)
ALS (133)
Alzheimer's disease (1035)
Antibody-drug conjugate (ADC) (241)
Approvals (6066)
Artificial intelligence (259)
Autoimmune disease (113)
Automation (9)
Bankruptcy (105)
Best Places to Work (4619)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (102)
Brain cancer (45)
Breast cancer (344)
Cancer (3157)
Cardiovascular disease (239)
Career advice (148)
Career pathing (7)
CAR-T (220)
CDC (5)
Cell therapy (570)
Cervical cancer (14)
Clinical research (44077)
Collaboration (1156)
Company closure (2)
Compensation (607)
Complete response letters (39)
COVID-19 (1124)
CRISPR (86)
C-suite (551)
Cystic fibrosis (112)
Data (4373)
Denatured (15)
Depression (92)
Diabetes (256)
Diagnostics (1381)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (189)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (215)
Earnings (31746)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (52023)
Executive appointments (621)
FDA (7631)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (984)
Gene editing (182)
Generative AI (21)
Gene therapy (487)
GLP-1 (506)
Government (1157)
Grass and pollen (3)
Guidances (166)
Healthcare (6656)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (192)
Immuno-oncology (39)
Indications (66)
Infectious disease (1229)
Inflammatory bowel disease (159)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (168)
Interviews (18)
IPO (7386)
IRA (12)
Job creations (869)
Job search strategy (130)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (244)
Leadership (9)
Legal (1405)
Liver cancer (41)
Longevity (11)
Lung cancer (425)
Lymphoma (257)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2676)
Medtech (2685)
Mergers & acquisitions (6632)
Metabolic disorders (726)
Multiple sclerosis (111)
NASH (13)
Neurodegenerative disease (232)
Neuropsychiatric disorders (70)
Neuroscience (1972)
Neurotech (1)
NextGen: Class of 2026 (2042)
Non-profit (868)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (304)
Patient recruitment (333)
Peanut (43)
People (26709)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15605)
Phase 2 (20500)
Phase 3 (12946)
Pipeline (3277)
Policy (90)
Postmarket research (854)
Preclinical (6621)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (653)
Real estate (1451)
Recruiting (12)
Regulatory (9970)
Reports (19)
Research institute (988)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2008)
State (1)
Stomach cancer (6)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (337)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (31)
Last 7 days (345)
Last 30 days (1152)
Last 365 days (17961)
2026 (1689)
2025 (18230)
2024 (20675)
2023 (22578)
2022 (27011)
2021 (28004)
2020 (23522)
2019 (16320)
2018 (11796)
2017 (13817)
2016 (11918)
2015 (14427)
2014 (10424)
2013 (7514)
2012 (7565)
2011 (7641)
2010 (7444)
Location
Africa (156)
Alabama (65)
Alaska (2)
Arizona (72)
Arkansas (5)
Asia (18352)
Australia (3126)
California (7107)
Canada (1838)
China (780)
Colorado (247)
Connecticut (252)
Delaware (236)
Europe (39524)
Florida (905)
Georgia (210)
Hawaii (2)
Idaho (17)
Illinois (395)
India (35)
Indiana (160)
Iowa (8)
Japan (223)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (740)
Massachusetts (5600)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1663)
New Mexico (13)
New York (1767)
North Carolina (827)
North Dakota (6)
Northern California (3487)
Ohio (180)
Oklahoma (11)
Oregon (24)
Pennsylvania (1344)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2823)
Tennessee (40)
Texas (906)
United States (23484)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (45)
283,257 Results for "macrophage therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Macomics Announces Updated Data of the ENIGMAC Drug Discovery Platform and The Role of Macrophages in Fibrotic Disease
November 25, 2025
·
3 min read
Press Releases
Ashvattha Therapeutics Reports the Ability to Tune Nanomedicines to Image Neuroinflammation in Multiple Sclerosis Patients and Tumor Associated Macrophages in Cancer at SNMMI Annual Meeting
June 23, 2025
·
3 min read
Drug Development
Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024
Carisma Therapeutics Inc. announced new data demonstrating preclinical proof of concept using engineered anti-fibrotic macrophages for the treatment of liver fibrosis.
May 8, 2024
·
6 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Drug Development
Pheast Unveils First Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor
Pheast Therapeutics today announced the first presentation of preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key macrophage “don’t eat me” signal on cancer cells.
May 13, 2024
·
2 min read
BioForest
Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
Kineta, Inc. announced today that it will present at the 5th Annual Macrophage-Directed Therapies Summit, to be held on November 13-15, 2023 in Boston, MA.
November 9, 2023
·
1 min read
Business
Macomics and the Institute of Oncology Research (IOR, Switzerland) Announce Macrophage Scientific Collaboration in Prostate Cancer Drug Development
Macomics Ltd, a leader in macrophage drug discovery, announces that it has entered a scientific collaboration with Prof. Andrea Alimonti at IOR, one of Switzerland’s leading research institutes.
June 19, 2024
·
5 min read
Press Releases
Myllia Biotechnology Unveils First-Ever Platform Enabling Genome-Wide CRISPR Screens in Primary Human Macrophages and Dendritic Cells
The breakthrough VISTA™ platform opens new frontiers in drug target discovery and leverages sequencing technology from Ultima Genomics.
June 6, 2025
·
1 min read
Business
Macomics and IFOM (the AIRC Institute of Molecular Oncology) Announce Macrophage Scientific Collaboration
Macomics Ltd, a leader in macrophage drug discovery, announces that it has entered a scientific collaboration with Prof. Massimiliano Pagani from the IFOM, one of Italy’s leading research institutes in Cancer Research.
May 13, 2024
·
4 min read
Policy
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB, announced that the US Food and Drug Administration has granted Fast Track designation to emapalumab-lzsg being investigated as a potential therapeutic option in patients with Macrophage Activation Syndrome.
May 24, 2024
·
5 min read
1 of 28,326
Next
